<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04692857</url>
  </required_header>
  <id_info>
    <org_study_id>UTEM VOL FIBSI</org_study_id>
    <nct_id>NCT04692857</nct_id>
  </id_info>
  <brief_title>US-guided FICB After Hip Fracture: the Effect of the Local Anesthetic Volume on the Quality of Preoperative Analgesia</brief_title>
  <official_title>Ultrasound-guided Fascia Iliaca Compartment Block After Hip Fracture : the Effect of the Local Anesthetic Volume on the Quality of Preoperative Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Tunis El Manar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Tunis El Manar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      participants were randomly divided into three groups : group 30 , group 40 and group 50 . for&#xD;
      all the three groups an ultrasound guided supra-inguinal fascia iliaca block had been&#xD;
      performed.&#xD;
&#xD;
      for group 30 ,a volume of 30 ml of 0,2 % ropivacaine had been injected for group 40 ,a volume&#xD;
      of 40 ml of 0,2 % ropivacaine had been injected for group 50 ,a volume of 50 ml of 0,2 %&#xD;
      ropivacaine had been injected&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      participants were randomly divided into three groups : group 30 , group 40 and group 50 . for&#xD;
      all the three groups an ultrasound guided supra-inguinal fascia iliaca block had been&#xD;
      performed.&#xD;
&#xD;
      A linear ultrasound probe was placed in the sagittal plane to obtain an image of the superior&#xD;
      iliac spine.the fascia iliaca and sartorious,iliopsoas,and oblique internal muscles were&#xD;
      identified by sliding the probe medially. After identifiying the &quot;bow-tie sign&quot;formed by the&#xD;
      muscle fascias , an 50 mm needle was introduced 1-2 cm inferior to the inguinal&#xD;
      ligament.using an in-plane approch, the fascia iliaca was penetrated and hydrodissected ,&#xD;
      separating the fascia iliaca from the iliac muscle. in this created space a total volume of&#xD;
      30 ml, 40ml or 50ml of 0.2% ropivacaine was injected , respectively to group 30 ,group 40 and&#xD;
      group 50 .&#xD;
&#xD;
      pain score at rest and with a straight leg raise of the affected limb to 15 degrees were&#xD;
      assessed before and 30 minutes after block performance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2, 2020</start_date>
  <completion_date type="Actual">August 31, 2020</completion_date>
  <primary_completion_date type="Actual">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in pain score on movement</measure>
    <time_frame>before and 30 minutes after block placement</time_frame>
    <description>change in verbal ranking scale(( vrs) with 0 indicating no pain and 10 indicating the worst imaginable pain)) during passive leg elevation to 15 degrees of the affected limb , before and 30 minutes after block placement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in pain score at rest</measure>
    <time_frame>before and 30 minutes after block placement</time_frame>
    <description>change in verbal ranking scale(( vrs) with 0 indicating no pain and 10 indicating the worst imaginable pain)) at rest, before and 30 minutes after block placement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessement of sensory block</measure>
    <time_frame>30 minutes after block placement</time_frame>
    <description>sensory assessment of Femoral nerve , obturator nerve, and lateral femoral cutaneous nerve using the cold test . in the anterior , medial and lateral aspects of the thigh.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Hip Fractures</condition>
  <arm_group>
    <arm_group_label>group 30</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants received a supra inguinal fascia iliaca compartment block with 30 ml of 0.2% ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 40</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants received a supra inguinal fascia iliaca compartment block with 40 ml of 0.2% ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 50</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants received a supra inguinal fascia iliaca compartment block with 50 ml of 0.2% ropivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>supra inguinal fascia iliaca block</intervention_name>
    <description>injection of 30,40 or 50 ml of 0.2 ropivacaine .</description>
    <arm_group_label>group 30</arm_group_label>
    <arm_group_label>group 40</arm_group_label>
    <arm_group_label>group 50</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients aged above 65 years , american society of anesthesiologists physical status I&#xD;
             to III , and with body mass index (BMI) of 35 kg/m² or less , undergoing hip fracture&#xD;
             surgical repair .&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inability or refusal to sign informed consent&#xD;
&#xD;
          -  younger than 65 years&#xD;
&#xD;
          -  BMI greater than 35 kg/m²&#xD;
&#xD;
          -  presence of contraindications for regional nerve block or spinal anesthesia&#xD;
&#xD;
          -  impaired cognition or dementia&#xD;
&#xD;
          -  multiple fractures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mechaal benali, PROFESSOR</last_name>
    <role>Study Chair</role>
    <affiliation>university manar Tunis tunisia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mechaal Benali</name>
      <address>
        <city>Nabeul</city>
        <state>Mrezga</state>
        <zip>8000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 29, 2020</study_first_submitted>
  <study_first_submitted_qc>December 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>January 2, 2021</last_update_submitted>
  <last_update_submitted_qc>January 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Tunis El Manar</investigator_affiliation>
    <investigator_full_name>Mechaal Benali</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

